The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Summary

The purpose of our research is to clarify the therapeutic efficacy and safety of Finerenone in patients with Primary Aldosteronism and explore the effective clinical predictive indicators of Finerenone in the treatment of Primary Aldosteronism.

Timeline

Start

2024-03-01

Primary completion

2025-06-01

Completion

2025-06-01

Publications

• Li P, Yang F, Lou Y, Zhang Z, Du Y, Zhang J, Ren Y, Tong A, Xie Z, Shi B, Liu J, Liu L, Zhu D. Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Multicenter Prospective Study. Hypertension. 2026 May;83(5):e26048. doi: 10.1161/HYPERTENSIONAHA.125.26048. Epub 2026 Jan 22.

Drugs

Indications